Intelligent Bio Solutions (INBS) Current Deferred Revenue (2021 - 2025)

Intelligent Bio Solutions' Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $271780.0 for Q2 2025.

• In Q2 2025, Current Deferred Revenue changed N/A year-over-year to $271780.0; the TTM figure through Jun 2025 stood at $271780.0 (changed N/A YoY), while the FY2025 annual figure was $271780.0, changed N/A from the prior year.
• Current Deferred Revenue was $271780.0 for Q2 2025 at Intelligent Bio Solutions, down from $2.3 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $4.7 million in Q2 2021 to a low of $60413.0 in Q3 2022.
• Historically, Current Deferred Revenue has averaged $2.1 million across 5 years, with a median of $2.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue slumped 96.7% in 2022, then jumped 3609.35% in 2023.
• A 5-year view of Current Deferred Revenue shows it stood at $3.4 million in 2021, then tumbled by 37.08% to $2.2 million in 2022, then climbed by 12.95% to $2.4 million in 2023, then decreased by 5.44% to $2.3 million in 2024, then plunged by 88.18% to $271780.0 in 2025.
• The last three Current Deferred Revenue figures came in at $271780.0 (Q2 2025), $2.3 million (Q1 2025), and $2.3 million (Q4 2024), per Business Quant data.